Stock DNA
Pharmaceuticals & Biotechnology
CNY 4,177 Million (Mid Cap)
12.00
NA
3.91%
-0.03
12.44%
1.35
Revenue and Profits:
Net Sales:
948 Million
(Quarterly Results - Jun 2026)
Net Profit:
116 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
41.95%
0%
41.95%
6 Months
26.35%
0%
26.35%
1 Year
30.61%
0%
30.61%
2 Years
45.91%
0%
45.91%
3 Years
25.88%
0%
25.88%
4 Years
50.61%
0%
50.61%
5 Years
57.24%
0%
57.24%
Zhuzhou Qianjin Pharmaceutical Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-0.77%
EBIT Growth (5y)
1.08%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.23
Sales to Capital Employed (avg)
1.24
Tax Ratio
14.76%
Dividend Payout Ratio
57.18%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
25.59%
ROE (avg)
15.82%
Valuation key factors
Factor
Value
P/E Ratio
12
Industry P/E
Price to Book Value
1.50
EV to EBIT
12.50
EV to EBITDA
9.90
EV to Capital Employed
1.51
EV to Sales
1.26
PEG Ratio
0.52
Dividend Yield
3.33%
ROCE (Latest)
12.09%
ROE (Latest)
12.44%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY
Jun'26
Jun'25
Change(%)
Net Sales
948.00
813.00
16.61%
Operating Profit (PBDIT) excl Other Income
160.10
122.50
30.69%
Interest
0.00
0.00
Exceptional Items
-1.10
0.30
-466.67%
Consolidate Net Profit
115.70
101.70
13.77%
Operating Profit Margin (Excl OI)
136.00%
115.80%
2.02%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2026 is 16.61% vs -11.97% in Jun 2025
Consolidated Net Profit
YoY Growth in quarter ended Jun 2026 is 13.77% vs 15.44% in Jun 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
3,599.90
3,591.50
0.23%
Operating Profit (PBDIT) excl Other Income
483.30
401.40
20.40%
Interest
5.70
8.50
-32.94%
Exceptional Items
3.20
3.60
-11.11%
Consolidate Net Profit
375.70
302.60
24.16%
Operating Profit Margin (Excl OI)
99.80%
78.20%
2.16%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 0.23% vs -4.78% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 24.16% vs -23.39% in Dec 2024
About Zhuzhou Qianjin Pharmaceutical Co., Ltd. 
Zhuzhou Qianjin Pharmaceutical Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






